Skip to main content

Peer Review reports

From: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Original Submission
10 Aug 2017 Submitted Original manuscript
26 Sep 2018 Author responded Author comments - Wesley de Jong
7 Apr 2018 Reviewed Reviewer Report - Anamika Misra
Resubmission - Version 2
26 Sep 2018 Submitted Manuscript version 2
27 Mar 2019 Author responded Author comments - Wesley de Jong
11 Oct 2018 Reviewed Reviewer Report - Anamika Misra
Resubmission - Version 3
27 Mar 2019 Submitted Manuscript version 3
Publishing
6 May 2019 Editorially accepted
17 Jun 2019 Article published 10.1186/s13063-019-3409-1

You can find further information about peer review here.

Back to article page